RANDOMIZED CONTROLLED TRIAL OF OLANZAPINE FOR THE CONTROL OF CHEMOTHERAPY-INDUCED VOMITING IN CHILDREN RECEIVING CHEMOTHERAPY FOR HEMATOPOIETIC STEM CELL TRANSPLANT CONDITIONING

Registry ID

1000053716

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

THE HOSPITAL FOR SICK CHILDREN

Start date

2021-05-03

Last update

2017-01-11

Conditions

• NAUSEA AND VOMITING
• HEMATOPOIETIC STEM CELL TRANSPLANT

Related clinical trials

• ADDING APREPITANT TO A MULTIMODAL STRATEGY FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING IN HIGH-RISK PATIENTS UNDERGOING OUTPATIENT SURGERY
• A RANDOMIZED CONTROLLED TRIAL COMPARING APREPITANT TO STANDARD OF CARE FOR POSTOPERATIVE NAUSEA AND VOMITING PROPHYLAXIS IN CHILDREN UNDERGOING SCOLIOSIS SURGERY: THE APRE-PONV TRIAL
• RANDOMIZED, DOUBLE-BLIND, PHASE 2/3 STUDY OF IV AMISULPRIDE AS PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING IN PEDIATRIC PATIENTS
• PHASE 3 MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VIRALYM-M (ALVR105) FOR THE TREATMENT OF PATIENTS WITH VIRUS-ASSOCIATED HEMORRHAGIC CYSTITIS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT
• PLATELET TRANSFUSIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION - THE PATH PHASE III TRIAL
• NOVEL PULMONARY FUNCTION MEASURES FOR DIAGNOSIS OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS) FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN CHILDREN.

View on source registry